ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · IEX Real-Time Price · USD
9.16
+0.14 (1.55%)
At close: May 17, 2024, 4:00 PM
9.65
+0.49 (5.35%)
After-hours: May 17, 2024, 5:37 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $620.62 million as of May 17, 2024. Its market cap has increased by 166.25% in one year.
Market Cap
620.62M
Enterprise Value
303.84M
1-Year Change
166.25%
Ranking
Category
Stock Price
$9.16
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $709.80M to $620.62M, a decrease of -12.56%. That is a compound annual growth rate of -3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 617.60M | 1.56% |
| May 16, 2024 | 608.10M | -3.12% |
| May 15, 2024 | 627.70M | 2.41% |
| May 14, 2024 | 612.90M | 1.34% |
| May 13, 2024 | 604.80M | -0.21% |
| May 10, 2024 | 606.10M | -5.37% |
| May 9, 2024 | 640.50M | -1.05% |
| May 8, 2024 | 647.30M | -0.09% |
| May 7, 2024 | 647.90M | 2.56% |
| May 6, 2024 | 631.70M | -3.44% |
| May 3, 2024 | 654.20M | 2.00% |
| May 2, 2024 | 641.40M | 2.04% |
| May 1, 2024 | 628.60M | 5.66% |
| Apr 30, 2024 | 594.90M | 7.29% |
| Apr 29, 2024 | 554.50M | 1.99% |
| Apr 26, 2024 | 543.70M | 5.21% |
| Apr 25, 2024 | 516.80M | -5.07% |
| Apr 24, 2024 | 544.40M | -7.87% |
| Apr 23, 2024 | 590.90M | 0.58% |
| Apr 22, 2024 | 587.50M | -5.12% |
| Apr 19, 2024 | 619.20M | -3.36% |
| Apr 18, 2024 | 640.70M | -2.57% |
| Apr 17, 2024 | 657.60M | 3.28% |
| Apr 16, 2024 | 636.70M | -0.95% |
| Apr 15, 2024 | 642.80M | -2.65% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exscientia | 630.11M |
| SI-BONE | 627.55M |
| Mind Medicine (MindMed) | 627.46M |
| Aerovate Therapeutics | 625.43M |
| Valneva SE | 619.22M |
| Phathom Pharmaceuticals | 611.69M |
| enGene Holdings | 600.65M |
| GeneDx Holdings | 599.64M |